Advanced Bifurcation Systems

Advanced Bifurcation Systems has disruptive technology for left main heart disease, stenting coronary arteries at their branch points. This platform is a paradigm shift in interventional cardiology. The ABS platform is protected by more than 36 issued and 12 pending patents and will become the “standard of care” in the $2.5 billion global bifurcations market. Every year millions of patients around the world with heart disease present to doctors who find they are faced with either a Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Grafting (CABG). Advanced Bifurcation Systems or ABS wants to transform the open heart surgery. A quarter of those requiring stenting will have bifurcation lesions, meaning a build-up of plaque that is blocking or about to block blood flow to the heart at a place where the blood vessel divides in two. That condition, until now, has had no best practice solution.